Sievers M L, Nelson R G, Bennett P H
Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Arizona, USA.
Diabetes Care. 1996 Feb;19(2):107-11. doi: 10.2337/diacare.19.2.107.
To compare sequential trends in overall and cause-specific death rates for diabetic and nondiabetic Pima Indians.
Underlying causes of death in Pimas aged > or = 15 years old were determined for the years 1975-1989 from review of death certificates and medical records. Overall and cause-specific death rates were compared for consecutive intervals.
The all-causes death rate, age- and sex-adjusted, did not change significantly between the first and second halves of the study for diabetic (death rate ratio [DRR] = 0.99, 95% CI 0.70-1.4) or nondiabetic Pimas (DRR = 0.92, 95% CI 0.74-1.1). Among diabetic Pimas, however, the death rate for diabetic nephropathy declined from 2.7 to 1.5/1,000 person-years (DRR = 0.55, 95% CI 0.33-0.93), with ischemic heart disease (IHD) replacing diabetic nephropathy as the leading cause in the second half (DRR = 1.5, 95% CI 0.91-2.6). For diabetic and nondiabetic Pimas combined, the death rate in three consecutive 5-year periods declined progressively for alcoholic liver disease (P = 0.024) and external causes of death (P = 0.016), the largest component of which was automobile accidents.
The decrease in death rate for diabetic nephropathy may be a result of greater access to and improvements in renal replacement therapy. Because of shared risk factors, however, the IHD death rate increased and largely offset the decrease in diabetic nephropathy deaths. The decline in deaths from alcoholic liver disease and from automobile accidents parallels the national trend.
比较糖尿病和非糖尿病皮马印第安人的总体死亡率及特定病因死亡率的连续变化趋势。
通过审查死亡证明和医疗记录,确定了1975年至1989年期间15岁及以上皮马人的潜在死因。对连续时间段的总体死亡率和特定病因死亡率进行了比较。
在研究的前半段和后半段之间,糖尿病皮马人(死亡率比[DRR]=0.99,95%可信区间0.70-1.4)或非糖尿病皮马人(DRR=0.92,95%可信区间0.74-1.1)经年龄和性别调整后的全因死亡率没有显著变化。然而,在糖尿病皮马人中,糖尿病肾病的死亡率从2.7降至1.5/1000人年(DRR=0.55,95%可信区间0.33-0.93),缺血性心脏病(IHD)在下半年取代糖尿病肾病成为主要死因(DRR=1.5,95%可信区间0.91-2.6)。对于糖尿病和非糖尿病皮马人合并而言,连续三个5年期间酒精性肝病(P=0.024)和外部死因(P=0.016)的死亡率逐渐下降,其中最大的组成部分是汽车事故。
糖尿病肾病死亡率的下降可能是肾替代治疗可及性提高和改善的结果。然而,由于共同的风险因素,缺血性心脏病死亡率上升,在很大程度上抵消了糖尿病肾病死亡人数的下降。酒精性肝病和汽车事故导致的死亡人数下降与全国趋势相似。